CIR circadian technologies limited

extraordinary company presentation today

  1. 2,630 Posts.
    lightbulb Created with Sketch. 4
    Much promising news - but look at this statement:

    Cancers of Unknown Primaries (CUP) Molecular Diagnostic - release 2H/2010, potential for up to 100k tests pa in USA alone, test to sell for between $2k and $4k each. To keep arithmetic simple - 100k tests worldwide at $2k each is annual revenue of $200m!!

    Could someone check this for me - sounds too good to be true! btw - sp on a roll - so my interpretation may be correct!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.